CD8A and neoplasm: Using PET-derived measures of the tumor microenvironment prior to and shortly after treatment initiation with immunotherapy, a non-invasive, early readout of intended biological effect can be obtained, for example, induced PD-L1 expression or CD8+ T-cell influx.